Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Semeru volcano — the highest volcano on Java — erupted on the afternoon of November 19, 2025, with pyroclastic flows racing ...

On October 29, 2025, in Java, Indonesia, @resepherey shared a funny video capturing an unexpected mishap during a shared mealtime. In the video, a group of friends is enjoying a meal together in a hut ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

HackerRank offers a good amount of free coding challenges and practice problems for individuals looking to hone their skills. While basic access is free, HackerRank has premium features and ...

Sora is a generative video model developed by OpenAI that transforms text descriptions, images or video inputs into short ...

How Ethereum’s Fusaka upgrade scales the L1 and the L2s — explained for ordinary crypto fans without the usual baffling ...

The sun’s current 11-year activity cycle has already peaked—but extreme outbursts from our star may still be in store ...